There are many nutraceuticals in today’s market that contain some of our key ingredients. Unfortunately, most of them are arbitrary combinations of ingredients plus additives. We have numerous goals in developing our line of unique nutraceuticals. First and foremost our nutraceuticals must be effective, safe and tolerable. Research and attention are put into each of our key ingredient’s source and purity as well as the molecular size and health concern. The exclusive Olive Kernel Oil distinctive to our formulations is used for the greatest absorption of key ingredients. One other goal is to develop nutraceuticals that address the current and underlying needs of our customers with inflammatory diseases.
We identify these needs as:

BLOCKING the triggers of inflammatory diseases
REDUCE and relieve present symptoms of swelling caused by current inflammatory diseases
REPAIR and RENEW areas damaged by the activation and secretion from stimulated mast cells
PROTECT existing cells from further damage
PROMOTE maximum absorption of key ingredients

We are pleased and proud to offer a line of nutraceuticals that meet and exceed these goals.
 
REFERENCES:
Theoharides TC, Tsilioni I, Patel AB, Doyle R. Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl Psychiatry. 2016 Jun 28;6(6):e844. 
Tsilioni I, Taliou A, Francis K, Theoharides TC. Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl Psychiatry. 2015 Sep 29;5:e647. 
Tsilioni I, Taliou A, Francis K, Theoharides TC. Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl Psychiatry. 2015 Sep 29;5:e647. 
Theoharides TC, Conti P, Economu M. Brain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolin. J Clin Psychopharmacol. 2014 Apr;34(2):187-9.